Medical News

RSS

HPV test could help predict risk of cervical cancer, but more research needed

Testing for the human papillomavirus (HPV) - the major cause of cervical cancer - may not help to identify women who are at risk of the disease, a new UK study suggests.

24 Mar 2010

Study indicates binge drinking does not impact students' test performance

In a first-of-its kind controlled experiment, researchers from the Boston University School of Public Health (BUSPH) and Brown University have found that surprisingly, binge drinking the night before a test does not impact college students' test performance - although it can affect their moods, attention and reaction times.

24 Mar 2010

FDA approves Aspyra's Picture Archive Communication System

Aspyra, Inc. today announced that they have received FDA 510(k) marketing clearance for AccessNET, the Company’s PACS (Picture Archive Communication System) product with the capability to view digital mammography studies for diagnostic interpretation using FDA approved monitors.

23 Mar 2010

AMA gives qualified support to health bill, Texas docs disagree

Austin American-Statesman: The Texas Medical Association split with the American Medical Association to announce its opposition to the health care bill that passed Sunday, saying: "We are disappointed and saddened that Congress and President Obama would pass a half-baked Senate proposal and call it 'Health System Reform.' The bill is simply bad medicine for patients and the state of Texas."

23 Mar 2010

New MIS Retractor System from Aesculap Implant Systems

Aesculap Implant Systems, LLC is pleased to announce the launch of the Spyder Minimally Invasive Spinal Retractor System.

23 Mar 2010

Age and gender play a major role in how people respond to stress

Age and gender play a major role in how people respond to stress, according to a new study on 20-to-64-year-olds. Published in the journal Psychophysiology, the investigation was led by scientists from the Universit- de Montr-al and the Montreal Heart Institute in collaboration with colleagues from the Universit- du Qu-bec - Montr-al and McGill University.

23 Mar 2010

Medx Health acquires Canadian operations of Reimers & Janssen GmbH

MedX Health Corp., a global leader in drug free, non-invasive low level laser and light therapy for tissue repair and pain relief, today announced it has acquired the Canadian operations of 27 year old laser pioneer, Reimers & Janssen GmbH (herein after "RJ-Laser"), providing an expanded line of products, with improved product features, within MedX's existing rehab/chiropractic, dental, and acupuncture laser and light markets, as well as approved products ready for launch to Veterinarians and Dermatologists.

23 Mar 2010

Some GOP states mounting legal challenges to health bill

The New York Times: "Officials in a dozen states who oppose the health care bill say they hope to block it in court by arguing that requiring people to buy health insurance is an unprecedented intrusion by the federal government into people's lives — the equivalent of going a step beyond simply regulating automobiles to requiring people to buy a car.

23 Mar 2010

Pluristem Therapeutics receives European Patent on core 3D cell expansion technology

Pluristem Therapeutics Inc. today announced that it has been granted a European Patent on its core 3D cell expansion technology. The granting of the European patent follows the issuance of several corresponding US patents as well as corresponding patents in ten additional jurisdictions.

23 Mar 2010

ClaimRemedi to provide revenue cycle management solutions for customers of HealthPac Computer Systems

ClaimRemedi, a provider of claim lifecycle management solutions, announced recently that they have signed an agreement with HealthPac Computer Systems, Inc., a Savannah, GA based Practice Management and Medical Billing software company. Under the agreement, ClaimRemedi will provide a complete end-to-end revenue cycle management solution for HealthPac customers.

23 Mar 2010

Garnet BioTherapeutics commences treatment in GBT009 trial for incisional wounds following breast reconstruction surgery

Garnet BioTherapeutics, Inc., a regenerative medicine company focused on developing cell based therapies, today announced that the first patient has been treated in a Phase 2 multicenter, double-blind, placebo-controlled study of its lead product candidate GBT009 at Unity Hospital in Rochester, New York. GBT009 gives off a variety of pro-regenerative growth factors and cytokines which help repair damaged tissue and reduce inflammation, ultimately augmenting the body's ability to heal itself.

23 Mar 2010

St. Jude Medical's Brio DBS system for treating Parkinson’s disease receives Australian TGA approval

St. Jude Medical, Inc., a global medical device company, today announced regulatory and reimbursement approval from the Australian Therapeutic Goods Administration of its Brio™ deep brain stimulation system for treating the symptoms of Parkinson’s disease.

23 Mar 2010

Portola Pharmaceuticals commences Phase 1 trial of PRT062607 for chronic inflammatory diseases

Portola Pharmaceuticals, Inc. today announced that it has initiated its first in human Phase 1 trial in healthy volunteers of PRT062607, a novel, oral Syk-specific kinase inhibitor in development to treat chronic inflammatory diseases, including rheumatoid arthritis (RA), and certain cancers, including non-Hodgkin's lymphoma and chronic lymphocytic leukemia. In preclinical in vivo models of RA, PRT062607 was shown to reduce inflammation in a dose-dependent manner.

23 Mar 2010

Merck Serono, EMD Serono suspend global clinical development program for Stimuvax temporarily

Oncothyreon Inc. today announced that Merck Serono, a division of Merck KGaA of Darmstadt, Germany, and its U.S. affiliate, EMD Serono, Inc., have temporarily suspended the worldwide clinical development program for Stimuvax(R) (BLP25 liposomal vaccine). The suspension is the result of a suspected unexpected serious adverse reaction in a patient with multiple myeloma participating in an exploratory clinical trial.

23 Mar 2010

FDA approves OrSense's NBM-200MP non-invasive oximetry and low signal oximetry sensor

OrSense Ltd., developer of monitors for non-invasive measurements of various blood parameters, announced today it has received U.S. Food and Drug Administration (FDA) approval for NBM-200MP, a non-invasive oximetry and low signal oximetry sensor.

23 Mar 2010

Celladon Corporation receives USPTO notice of allowance covering MYDICAR for advanced heart failure

Celladon Corp. announced today that the United States Patent and Trademark Office (USPTO) has granted a notice of allowance for a broad patent covering the company's lead drug candidate MYDICAR®, a genetically targeted enzyme replacement therapy for advanced heart failure. The patent will be issued to The Regents of the University of California and licensed exclusively to Celladon.

23 Mar 2010

Texas jury returns binding verdict of invalidity on two Covidien's patent claims covering trocar seal technology

Applied Medical announced today that a United States District Court jury for the Eastern District of Texas returned a binding verdict of invalidity of two claims of a Covidien patent covering trocar seal technology.

23 Mar 2010

ReGear Life Sciences achieves preferred partner status with Genesis Rehab Services

ReGear Life Sciences, Inc. announces that it has been named a Preferred Partner to Genesis Rehab Services.

23 Mar 2010

NMA to discuss impact of historic health care reform legislation on health disparities

With the passage of the historic health care legislation, the National Medical Association (NMA), the nation's oldest and largest organization representing the interests of 30,000 African American physicians will hold a press conference to address health care reform implementation and its impact on health disparities.

23 Mar 2010

Mach One completes “Definitive Agreement” for merger and acquisition of White Hat Brands

Mach One Corporation, a global wellness solutions company, today announced the completion of a “Definitive Agreement” for the terms and conditions for the merger and acquisition of White Hat Brands, LLC, producers of a variety of all natural, multi-vitamin-fortified juice beverages for children under the brand name Dog On It!™.

23 Mar 2010

Medical News

HPV test could help predict risk of cervical cancer, but more research needed

Study indicates binge drinking does not impact students' test performance

FDA approves Aspyra's Picture Archive Communication System

AMA gives qualified support to health bill, Texas docs disagree

New MIS Retractor System from Aesculap Implant Systems

Age and gender play a major role in how people respond to stress

Medx Health acquires Canadian operations of Reimers & Janssen GmbH

Some GOP states mounting legal challenges to health bill

Pluristem Therapeutics receives European Patent on core 3D cell expansion technology

ClaimRemedi to provide revenue cycle management solutions for customers of HealthPac Computer Systems

Garnet BioTherapeutics commences treatment in GBT009 trial for incisional wounds following breast reconstruction surgery

St. Jude Medical's Brio DBS system for treating Parkinson’s disease receives Australian TGA approval

Portola Pharmaceuticals commences Phase 1 trial of PRT062607 for chronic inflammatory diseases

Merck Serono, EMD Serono suspend global clinical development program for Stimuvax temporarily

FDA approves OrSense's NBM-200MP non-invasive oximetry and low signal oximetry sensor

Celladon Corporation receives USPTO notice of allowance covering MYDICAR for advanced heart failure

Texas jury returns binding verdict of invalidity on two Covidien's patent claims covering trocar seal technology

ReGear Life Sciences achieves preferred partner status with Genesis Rehab Services

NMA to discuss impact of historic health care reform legislation on health disparities

Mach One completes “Definitive Agreement” for merger and acquisition of White Hat Brands

Synthetic Biology and the Pursuit of Living Diagnostics

Modular, Scalable, Intelligent: How n6 Is Rethinking NGS Library Prep

Shaping the future of lab automation through AI and robotics

Latest News